# Ultrasound-Innovation Medtech S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ultrasound-innovation-medtech-s-l

- Industry: Medical Devices & Equipment
- Headquarters: Spain
- Website: www.innitius.com
- Total disclosed funding: $0.6M
- Latest round: Seed (Jul 25, 2020)
- Investors on record: 4

## About

Based in Spain, Ultrasound-Innovation Medtech S.L. specializes in women's health diagnostics, developing innovative ultrasound technology to improve the assessment of preterm labor risk.Ultrasound-Innovation Medtech S.L. focuses on revolutionizing women's health diagnostics with its flagship product, the Fine Birth device. The company was founded in 2017 by a team including Alberto Palma, Carlos Alvarez-Iglesias, Rafael Beltran, and Rubén Molina, who currently serves as CEO. The company has completed 4 deals since its inception, with its most recent funding round raising EUR 1.8 million on February 15, 2023, from various investors including Caju Capital and Clave Capital.Innitius specializes in advancing women's health diagnostics, with its core product being the Fine Birth device. This portable diagnostic tool enables OB/GYN doctors to assess the risk of spontaneous preterm delivery in real time, specifically addressing the critical need to differentiate between true and false preterm labor threats. Fine Birth is designed to provide risk assessments within a 7-day window after an event, significantly reducing the clinical repercussions and costs associated with over-treating false preterm labor cases. The primary users of this technology are healthcare professionals in the obstetrics and gynecology field, particularly in regions where preterm labor is a common concern. While the company is based in Spain, its product aims to serve international markets where the demand for accurate and efficient preterm labor diagnostics is growing.The revenue model for Innitius is based on B2B transactions with healthcare providers, specifically OB/GYN clinics and hospitals that incorporate the Fine Birth device into their patient care protocols. This structure involves direct sales agreements in which healthcare facilities purchase the device along with any associated support services. The company offers product training and ongoing support, enhancing the overall value proposition for its clients. While specific pricing information for the Fine Birth device is not disclosed, the transaction framework is expected to facilitate both initial sales and potential recurring revenue through service agreements or supplementary diagnostic tools.In February 2023, Ultrasound-Innovation Medtech S.L. raised EUR 1.8 million in venture funding co-led by new investors Clave Mayor and Nara Capital, with participation from Caju Capital and Namarel Ventures, alongside returning investors Fundación Botín, Seed Capital de Bizkaia, and Women Angels for STEAM. The company plans to utilize this funding to enhance the development of its product range and expand into new markets, targeting regions with a high demand for women's health diagnostics. Upcoming product launches are anticipated to further improve the functionality of the Fine Birth device, although specific release dates have not been disclosed.

## Funding rounds

- Seed, Jul 25, 2020, $0.6M — Banco Santander, Seed Capital de Bizkaia, Women Angels for STEAM, Fundación Botín

## Investors

- Banco Santander — Seed
- Seed Capital de Bizkaia (https://capitalatlas.ai/funds/seed-capital-de-bizkaia) — Seed
- Women Angels for STEAM — Seed
- Fundación Botín — Seed